EP4255393
STAÐBUNDIN ROFLUMILAST FORMÚLA MEÐ SVEPPAEYÐANDI EIGINLEIKUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.12.2021EP published:
28.5.2025EP application number:
21840242.8
EP translation filed:
25.6.2025Grant published:
15.7.2025EPO information:
European Patent Register
Max expiry date:
2.12.2041Expiry date:
2.12.2026Next due date:
31.12.2026
Title in English:
TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIESLanguage of the patent:
English
Timeline
Today
3.12.2021EP application
28.5.2025EP Publication
25.6.2025Translation submitted
15.7.2025Registration published
2.12.2026Expires
Owner
Name:
Arcutis Biotherapeutics, Inc.Address:
3027 Townsgate Road, Suite 300, Westlake Village, CA 91361, US
Inventor
Name:
KATO, SaoriAddress:
Westlake Village, California 91361, US
Name:
BERK, David ReubenAddress:
Westlake Village, California 91361, US
Name:
BURNETT, Patrick EugeneAddress:
Westlake Village, California 91361, US
Name:
OSBORNE, DavidAddress:
Fort Collins, Colorado 80525, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
202063121299 PDate:
4.12.2020Country:
US
Classification
Categories:
A61K 31/137, A61K 9/00, A61K 31/201, A61K 31/343, A61K 31/4174, A61K 31/44, A61K 31/496, A61K 31/506, A61K 31/513, A61K 31/60, A61K 33/04, A61K 45/06, A61P 17/00, A61P 17/04, A61P 31/10, A61K 9/107, A61K 9/12
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 29.12.2025
Expires: 2.12.2026
Payer: Árnason Faktor ehf.